Entity Common Stock, Shares Outstanding of Spyre Therapeutics, Inc. from 08 Aug 2016 to 29 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Spyre Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 Aug 2016 to 29 Oct 2025.
  • Spyre Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 29 Oct 2025 was 77,592,130, a 51% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 77,592,130 +26,160,910 +51% 29 Oct 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 60,400,960 +9,608,586 +19% 31 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 60,353,561 +20,070,147 +50% 02 May 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 51,431,220 +47,382,293 +1170% 01 Nov 2024 10-Q/A 18 Nov 2024 2024 Q3
Q2 2024 50,792,374 -50,400,547 -50% 01 Aug 2024 10-Q/A 18 Nov 2024 2024 Q2
Q1 2024 40,283,414 -25,111,745 -38% 01 May 2024 10-Q/A 18 Nov 2024 2024 Q1
Q3 2023 4,048,927 -57,462,151 -93% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 101,192,921 +40,020,411 +65% 04 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 65,395,159 +14,975,337 +30% 02 May 2023 10-Q 11 May 2023 2023 Q1
Q3 2022 61,511,078 +12,191,120 +25% 28 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 61,172,510 +12,107,952 +25% 29 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 50,419,822 +2,403,930 +5% 28 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 49,319,958 +1,382,851 +2.9% 28 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 49,064,558 +4,464,711 +10% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 48,015,892 +3,422,128 +7.7% 12 Mar 2021 10-K 18 Mar 2021 2020 FY
Q3 2020 47,937,107 +18,951,589 +65% 02 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 44,599,847 +15,714,378 +54% 05 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 44,593,764 +15,773,864 +55% 01 May 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 28,985,518 +5,023,404 +21% 01 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 28,885,469 +6,890,437 +31% 01 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 28,819,900 +12,103,564 +72% 01 Mar 2019 10-K 07 Mar 2019 2018 FY
Q3 2018 23,962,114 +7,317,791 +44% 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 21,995,032 +5,542,772 +34% 03 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 16,716,336 +3,264,076 +24% 08 Mar 2018 10-K 13 Mar 2018 2017 FY
Q3 2017 16,644,323 +3,213,490 +24% 03 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 16,452,260 +3,040,488 +23% 07 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 13,452,260 23 Mar 2017 10-K 23 Mar 2017 2016 FY
Q3 2016 13,430,833 09 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 13,411,772 08 Aug 2016 10-Q 09 Aug 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.